| |
| |
|
| Insider
Information: |
Virgin Herbert |
| Relationship: |
EVP, Research & CSO |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
262,500 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
262,500 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vir Biotechnology, Inc. |
VIR |
EVP, Research & CSO |
2022-08-09 |
262,500 |
2020-05-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2022-08-09 |
4 |
OE |
$1.53 |
$189,658 |
D/D |
78,093 |
262,500 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2022-03-10 |
4 |
OE |
$1.53 |
$13,770 |
D/D |
9,000 |
184,407 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2022-02-22 |
4 |
AS |
$30.00 |
$41,250 |
D/D |
(1,375) |
175,407 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2022-02-22 |
4 |
OE |
$1.53 |
$2,104 |
D/D |
1,375 |
176,782 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2022-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
70,000 |
175,407 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2022-02-17 |
4 |
S |
$31.93 |
$73,218 |
D/D |
(2,293) |
105,407 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2022-02-08 |
4 |
OE |
$1.53 |
$2,104 |
D/D |
1,375 |
109,075 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2022-02-08 |
4 |
AS |
$33.94 |
$46,668 |
D/D |
(1,375) |
107,700 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2022-01-25 |
4 |
AS |
$32.46 |
$44,633 |
D/D |
(1,375) |
107,700 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2022-01-25 |
4 |
OE |
$1.53 |
$2,104 |
D/D |
1,375 |
109,075 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2022-01-11 |
4 |
OE |
$1.53 |
$2,104 |
D/D |
1,375 |
109,075 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2022-01-11 |
4 |
AS |
$35.10 |
$48,263 |
D/D |
(1,375) |
107,700 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-12-28 |
4 |
AS |
$39.95 |
$54,931 |
D/D |
(1,375) |
107,700 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-12-28 |
4 |
OE |
$1.53 |
$2,104 |
D/D |
1,375 |
109,075 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-12-15 |
4 |
OE |
$1.53 |
$4,208 |
D/D |
2,750 |
110,450 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-12-15 |
4 |
AS |
$50.00 |
$137,500 |
D/D |
(2,750) |
107,700 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-12-14 |
4 |
AS |
$45.88 |
$63,085 |
D/D |
(1,375) |
107,700 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-12-14 |
4 |
OE |
$1.53 |
$2,104 |
D/D |
1,375 |
109,075 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-11-16 |
4 |
AS |
$32.67 |
$44,921 |
D/D |
(1,375) |
107,700 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-11-16 |
4 |
OE |
$1.53 |
$2,104 |
D/D |
1,375 |
109,075 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-11-02 |
4 |
AS |
$36.94 |
$50,793 |
D/D |
(1,375) |
107,700 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-11-02 |
4 |
OE |
$1.53 |
$2,104 |
D/D |
1,375 |
109,075 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-10-19 |
4 |
OE |
$1.53 |
$2,104 |
D/D |
1,375 |
109,075 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-10-19 |
4 |
AS |
$38.87 |
$53,446 |
D/D |
(1,375) |
107,700 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-10-05 |
4 |
AS |
$33.75 |
$46,406 |
D/D |
(1,375) |
107,700 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
